Terumo Corporation is a prominent player in vascular closure devices market; it strengthened its portfolio with the acquisition of vascular closure products owned by St. Jude (U.S.). It has a strong product portfolio owing to its high expenditure on R&D. In 2015, the company invested USD 276 million on product innovation to enhance its product offerings. Owing to its wide product portfolio and efforts on innovation, Terumo is among the leaders in the vascular closure devices market.